# Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms

Study · id `cardio:ct-nct02225756` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02225756](<https://clinicaltrials.gov/study/NCT02225756>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02225756

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

## Technical summary

Registry record NCT02225756. Randomized; quadruple masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 360 participants (planned count; ClinicalTrials.gov record NCT02225756, source copy `cardio:ctgov-nct02225756-2015-06-03`, retrieved 2026-11-18)
- Start date: 2013-12 (registry gives no type) (ClinicalTrials.gov record NCT02225756, source copy `cardio:ctgov-nct02225756-2015-06-03`, retrieved 2026-11-18)
- Primary completion: 2017-09 (anticipated) (ClinicalTrials.gov record NCT02225756, source copy `cardio:ctgov-nct02225756-2015-06-03`, retrieved 2026-11-18)
- Completion: 2018-09 (anticipated) (ClinicalTrials.gov record NCT02225756, source copy `cardio:ctgov-nct02225756-2015-06-03`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT02225756, source copy `cardio:ctgov-nct02225756-2015-06-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02225756-2015-06-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms
- Acronym: ACA4
- Condition: Abdominal Aortic Aneurysm,
- Condition: Small Abdominal Aortic Aneurysm
- Intervention (Drug): Cyclosporine A
- Intervention (Drug): Cyclosporine A
- Intervention (Drug): Placebo
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 8d6bffd705928b9f7d4ff0256982be19d4784a710e6df033c76b7f66b823e814
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
